Install
Gene Therapy & Genomic Medicine
CRISPR edits, delivery vectors, rare‑disease trials, and approvals.
- 18 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Gene Therapy & Genomic Medicine
Genetic LifeSpan Marks IMUN™ Premiere With Cell-Processing and Cryopreservation Provider at New Jersey Facility
1+ hour, 47+ min ago (297+ words) The National Law Review Genetic LifeSpan Marks IMUN™ Premiere With Cell-Processing and Cryopreservation Provider at New Jersey Facility Genetic LifeSpan executives with Celularity leadership at the invitation-only IMUN™ premiere in Florham Park, New Jersey. Invitation-only event introduced Genetic LifeSpan’s IMUN…...
Applied Biologics Announces Manufacturing Milestone in APPB-515 Osteoarthritis Gene Therapy Program
14+ hour, 36+ min ago (572+ words) The Manila Times Successful production of reference protein advances proprietary protein engineering and gene therapy development program SCOTTSDALE, Ariz., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, LLC today announced the successful manufacture of the first recombinant reference protein for APPB-515, the Company’s…...
What 30 Years of Debate on Genetic Modification Missed
4+ hour, 23+ min ago (803+ words) A quarter-century ago, genetic modification stood as one of the most contentious political and environmental issues in New Zealand. Senior Lecturer in Environmental Policy, Lincoln University, New Zealand Senior Lecturer, Department of Tourism, Sport and Society, Lincoln University, New Zealand…...
Merck Opens New BioReliance Biologics Testing Facility in Darmstadt
18+ hour, 30+ min ago (257+ words) Merck has opened a new BioReliance® facility in Darmstadt, Germany, designed to provide biologics testing, Good Manufacturing Practice (GMP) release testing, and stability studies for the European market. The site aims to support the development and commercialization of biologic products…...
The Epitranscriptome Heads Toward Clinical Necessity
16+ hour, 35+ min ago (616+ words) Credit: Serg Myshkovsky / Getty Images A deep understanding of epitranscriptomics—RNA modifications—is the missing layer in the quest for more broadly effective precision medicines. That’s the view of Gudrun Stengel, PhD, CEO of Alida Biosciences, and the foundational belief…...
Could CRISPR correct CEP290 mutations in LCA10?
9+ hour, 21+ min ago (367+ words) The Problem of LCA10. When I stay up late at night and start fantasizing about all the great accomplishments humanity might reach in the future, I … Could CRISPR correct CEP290 mutations in LCA10? The Problem of LCA10.When I stay up late at night…...
Sanford Health researcher awarded $2.3M federal grant for kidney disease study
11+ hour, 48+ min ago (255+ words) SIOUX FALLS, S.D. (Dakota News Now) - Sanford Health researcher Kamesh Surendran, Ph.D., has received a $2.3 million grant from the National Institutes of Health to investigate a surprising phenomenon in the kidney. The R01 grant, totaling $2,314,660, will fund Surendran’s lab at Sanford Research…...
Claude's CRISPR-Like Enzyme Find: Intriguing, but Not Yet a Breakthrough - WOWTALE
12+ hour, 48+ min ago (296+ words) The system is built around a reverse transcriptase (RT), an enzyme that copies RNA into DNA. The RT itself, found in a jumbo phage, had turned up in earlier research. What Claude appears to have noticed first, according to Anthropic,…...
The Future of Gene Therapy: Market Innovations, Growth, and Trends
15+ hour, 49+ min ago (276+ words) Defence and aerospace organisations need to incorporate key strategic and technological advancements to stay effective Electric vehicles and autonomous technology are driving the transportation industry into a bold new era Chemical industries are being reshaped by demand for cleaner products,…...
Scope CRISPR-Based Antifungal Resistance Test Gets CE-IVDR
13+ hour, 54+ min ago (20+ words) Scope Biosciences Gains CE-IVDR for CRISPR-Based Antifungal Resistance Assay Genome Web Scope Biosciences Gains CE-IVDR for CRISPR-Based Antifungal Resistance Assay...